Multilevel barriers to communication in pediatric oncology: Clinicians' perspectives.

barriers communication pediatric oncology physician-patient relationship psychosocial oncology

Journal

Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236

Informations de publication

Date de publication:
15 06 2021
Historique:
revised: 08 12 2020
received: 15 09 2020
accepted: 26 12 2020
pubmed: 19 2 2021
medline: 8 3 2022
entrez: 18 2 2021
Statut: ppublish

Résumé

Communication serves several functions in pediatric oncology, but communication deficiencies persist. Little is known about the broad spectrum of barriers contributing to these deficiencies. Identifying these barriers will support new strategies to improve communication. The authors performed 10 focus groups on perceived communication barriers with nurses, nurse practitioners, physicians, and psychosocial professionals across 2 academic institutions. They analyzed transcripts by adapting a multilevel framework from organizational psychology. The authors identified 6 levels of barriers to communication from the clinicians' perspectives: individual, team, organization, collaborating hospital, community, and policy. Individual barriers were subdivided into clinician characteristics, family characteristics, or characteristics of the clinician-family interaction. Within each level and sublevel, several manifestations of barriers were identified. Some barriers, such as a lack of comfort with difficult topics (individual), cultural differences (individual), a lack of a shared team mental model (team), and time pressure (organization), manifested similarly across professions and institutions. Other barriers, such as a need for boundaries (individual), intimidation or embarrassment of family (individual), unclear roles and authority (team), and excessive logistical requirements (policy), manifested differently across professions. With the exception of collaborating hospitals, participants from all professions identified barriers from each level. Physicians did not discuss collaborating hospital barriers. Nurses, nurse practitioners, physicians, and psychosocial professionals experience communication barriers at multiple levels, which range from individual- to policy-level barriers. Yet their unique clinical roles and duties can lead to different manifestations of some barriers. This multilevel framework might help clinicians and researchers to identify targets for interventions to improve communication experiences for families in pediatric oncology. Clinicians and families experience many barriers to communication in pediatric oncology. The authors performed 10 focus groups with 59 clinicians who cared for children with cancer. In these focus groups, barriers to effective communication were discussed. In this article, the authors report on an analysis of the responses. Six levels of barriers to communication were found: individual, team, organization, collaborating hospital, community, and policy. With an understanding of these barriers, interventions can be developed to target these barriers in hopes of improving communication for parents and patients in pediatric oncology.

Sections du résumé

BACKGROUND
Communication serves several functions in pediatric oncology, but communication deficiencies persist. Little is known about the broad spectrum of barriers contributing to these deficiencies. Identifying these barriers will support new strategies to improve communication.
METHODS
The authors performed 10 focus groups on perceived communication barriers with nurses, nurse practitioners, physicians, and psychosocial professionals across 2 academic institutions. They analyzed transcripts by adapting a multilevel framework from organizational psychology.
RESULTS
The authors identified 6 levels of barriers to communication from the clinicians' perspectives: individual, team, organization, collaborating hospital, community, and policy. Individual barriers were subdivided into clinician characteristics, family characteristics, or characteristics of the clinician-family interaction. Within each level and sublevel, several manifestations of barriers were identified. Some barriers, such as a lack of comfort with difficult topics (individual), cultural differences (individual), a lack of a shared team mental model (team), and time pressure (organization), manifested similarly across professions and institutions. Other barriers, such as a need for boundaries (individual), intimidation or embarrassment of family (individual), unclear roles and authority (team), and excessive logistical requirements (policy), manifested differently across professions. With the exception of collaborating hospitals, participants from all professions identified barriers from each level. Physicians did not discuss collaborating hospital barriers.
CONCLUSIONS
Nurses, nurse practitioners, physicians, and psychosocial professionals experience communication barriers at multiple levels, which range from individual- to policy-level barriers. Yet their unique clinical roles and duties can lead to different manifestations of some barriers. This multilevel framework might help clinicians and researchers to identify targets for interventions to improve communication experiences for families in pediatric oncology.
LAY SUMMARY
Clinicians and families experience many barriers to communication in pediatric oncology. The authors performed 10 focus groups with 59 clinicians who cared for children with cancer. In these focus groups, barriers to effective communication were discussed. In this article, the authors report on an analysis of the responses. Six levels of barriers to communication were found: individual, team, organization, collaborating hospital, community, and policy. With an understanding of these barriers, interventions can be developed to target these barriers in hopes of improving communication for parents and patients in pediatric oncology.

Identifiants

pubmed: 33598930
doi: 10.1002/cncr.33467
pmc: PMC8154640
mid: NIHMS1666467
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2130-2138

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Organisme : American Society of Clinical Oncology

Informations de copyright

© 2021 American Cancer Society.

Références

Int Nurs Rev. 2011 Dec;58(4):443-9
pubmed: 22092322
PLoS One. 2019 Aug 22;14(8):e0221536
pubmed: 31437262
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Arch Pediatr Adolesc Med. 2009 Jun;163(6):519-24
pubmed: 19487607
Pediatr Blood Cancer. 2018 Aug;65(8):e27087
pubmed: 29697189
J Clin Oncol. 2014 Sep 20;32(27):3005-11
pubmed: 25024073
J Pediatr Oncol Nurs. 2003 Jul-Aug;20(4):175-91
pubmed: 14567565
Implement Sci. 2019 Jan 18;14(1):7
pubmed: 30658670
J Palliat Med. 2016 Jun;19(6):626-31
pubmed: 27115314
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
J Clin Oncol. 2011 May 20;29(15):2085-90
pubmed: 21464400
Pediatrics. 2020 Sep;146(3):
pubmed: 32820068
J Clin Oncol. 2003 Jun 1;21(11):2173-8
pubmed: 12775743
Support Care Cancer. 2020 Mar;28(3):1215-1222
pubmed: 31297592
J Pediatr Oncol Nurs. 2003 Nov-Dec;20(6):301-13
pubmed: 14738162
Pediatr Blood Cancer. 2020 Nov;67(11):e28399
pubmed: 32827346
Psychooncology. 2013 Mar;22(3):548-54
pubmed: 22228677
Pediatr Blood Cancer. 2020 Oct;67(10):e28607
pubmed: 32706453
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Acta Paediatr. 2019 Dec;108(12):2285-2291
pubmed: 31206784
Br J Cancer. 2013 Aug 20;109(4):836-43
pubmed: 23900218
Cancer. 2017 Oct 15;123(20):4031-4038
pubmed: 28369836
Cancer. 2020 Jan 15;126(2):416-424
pubmed: 31584705
Support Care Cancer. 2020 Sep;28(9):4467-4476
pubmed: 31927756
J Cancer Surviv. 2012 Sep;6(3):278-86
pubmed: 22544451

Auteurs

Bryan A Sisk (BA)

Division of Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.

Annie B Friedrich (AB)

Albert Gnaegi Center for Health Care Ethics, Saint Louis University, St. Louis, Missouri.

Erica C Kaye (EC)

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.

Justin N Baker (JN)

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Division of Quality of Life and Palliative Care, St. Jude Children's Research Hospital, Memphis, Tennessee.

Jennifer W Mack (JW)

Pediatric Oncology and Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

James M DuBois (JM)

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH